Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.

Amphoux A, Millan MJ, Cordi A, Bönisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S.

Eur J Pharmacol. 2010 May 25;634(1-3):1-9. doi: 10.1016/j.ejphar.2010.02.012. Epub 2010 Feb 17.

PMID:
20170649
2.

Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.

Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, Lejeune F, Rivet JM, Brocco M, Duqueyroix D, Nicolas JP, Boutin JA, Newman-Tancredi A.

J Pharmacol Exp Ther. 2001 Jun;297(3):876-87.

3.

Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.

Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verrièle L, Touzard M, Chaput C, Richard N, Millan MJ.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Aug;358(2):197-206.

PMID:
9750005
4.

S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.

Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A.

J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205.

5.

Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Blue DR Jr, Bonhaus DW, Ford AP, Pfister JR, Sharif NA, Shieh IA, Vimont RL, Williams TJ, Clarke DE.

Br J Pharmacol. 1995 May;115(2):283-94.

6.
7.
8.

In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.

Lehtimäki J, Leino T, Koivisto A, Viitamaa T, Lehtimäki T, Haapalinna A, Kuokkanen K, Virtanen R.

Eur J Pharmacol. 2008 Dec 3;599(1-3):65-71. doi: 10.1016/j.ejphar.2008.10.003. Epub 2008 Oct 9.

PMID:
18930723
9.
10.
11.

Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.

Audinot V, Fabry N, Nicolas JP, Beauverger P, Newman-Tancredi A, Millan MJ, Try A, Bornancin F, Canet E, Boutin JA.

Cell Signal. 2002 Oct;14(10):829-37.

PMID:
12135704
12.

Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.

Eltze M, Grebe T, Michel MC, Czyborra P, Ullrich B.

Eur J Pharmacol. 2002 May 17;443(1-3):151-68.

PMID:
12044805
14.

Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.

Barbieri A, Santagostino-Barbone MG, Zonta F, Lucchelli A.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jun;357(6):654-61.

PMID:
9686942
15.

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S.

Neuropharmacology. 2006 Jun;50(8):941-52. Epub 2006 Mar 31.

PMID:
16581093
16.

Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.

Corboz MR, Varty LM, Rizzo CA, Mutter JC, Rivelli MA, Wan Y, Umland S, Qiu H, Jakway J, McCormick KD, Berlin M, Hey JA.

Auton Autacoid Pharmacol. 2003 Aug;23(4):208-19.

PMID:
15084187
17.

The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.

Chess-Williams R, Chapple CR, Verfurth F, Noble AJ, Couldwell CJ, Michel MC.

Br J Pharmacol. 1996 Nov;119(6):1093-100.

18.

Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency.

Schömig E, Lazar A, Gründemann D.

Handb Exp Pharmacol. 2006;(175):151-80. Review.

PMID:
16722235
19.

[3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.

Ireland LM, Cain JC, Rotert G, Thomas S, Shoghi S, Hancock AA, Kerwin JF Jr.

Eur J Pharmacol. 1997 May 26;327(1):79-86.

PMID:
9185839
20.

Supplemental Content

Support Center